Article Details
Retrieved on: 2022-09-30 06:08:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Lund, Sweden , September 30, 2022 . Hansa Biopharma AB , "Hansa" (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here